Skip to main content
. 2014 Dec 9;9(12):e111317. doi: 10.1371/journal.pone.0111317

Figure 3. Effect of the peptide ANXA12–26 and antagonist Boc2 on the proliferation of Hep-2 cells.

Figure 3

Treatment with ANXA12–26 reduced the cellular growth. The antagonist Boc2 partially inhibited the anti-proliferative effect of ANXA12–26. The cells treated with Boc2 alone showed a level of proliferation similar to that of the control. The Hep-2 cells were seeded in MEM-Earle medium at a density of 2×106 cells in 75-cm2 culture flask, and then were incubated with serum-free medium 24 hours prior to the addition of ANXA12–26 (1 µM), ANXA12–26 (1 µM)+Boc (10 µM) or Boc (10 µM) alone. All of the experiments were performed in triplicate to confirm the results. Data are expressed as the mean ± SEM of the cell number ×106. ** P<0.01 and *** P<0.001 vs. control, ## P<0.01 and ### P<0.001 vs. ANXA12–26+Boc.